COMMUNIQUÉS West-GlobeNewswire

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
16/12/2025
– Webinar to be held Wednesday, December 17, 2025, at 1:00 p.m. ET – SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
16/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
16/12/2025
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will [...]
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
16/12/2025
CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 15, 2025 it granted stock options to purchase an aggregate of 21,399 shares of [...]
Valerie Health Raises $30M Series A to Bring AI Front Office to Independent Provider Groups
16/12/2025
Redpoint Ventures leads the round as Valerie’s embedded AI and human teams cut administrative costs, speed scheduling, and turn lost referrals into patient visits SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Valerie [...]
PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
16/12/2025
Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform transforming how [...]
Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection
16/12/2025
First-of-its-kind research offers participants exclusive access to combined oral and gut microbiome testing AUSTIN, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Tiny Health and Bristle Health are recruiting participants for [...]
Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
16/12/2025
Newborn screening is the only practical means of diagnosing MLD prior to the onset of symptoms, which is key to achieving optimal outcomes for children and their families with this rapidly progressive disease As of [...]
Pathway Health’s Lisa Thomson Receives 2026 McKnight’s Pinnacle Award
16/12/2025
LAKE ELMO, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Pathway Health , a leading provider of health care consulting services, interim and permanent talent, technology implementation, and training, is pleased to announce [...]
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance
16/12/2025
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA [...]
Market update
16/12/2025
Press Release Paris – December 16, 2025 - EUROAPI announced today that its main shareholders, Sanofi and EPIC Bpifrance, have agreed to extend further the duration of their lock-up until December 18, 2026, subject to [...]
Information marché
16/12/2025
Communiqué de presse Paris - Le 16 décembre 2025 - EUROAPI annonce, ce jour, que ses principaux actionnaires, Sanofi et EPIC Bpifrance, ont donné leur accord pour étendre la période de conservation de leurs actions [...]
Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer
16/12/2025
LOS ANGELES, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]
Simple Consult Expands Access to $29 Online Healthcare Across 19 States
16/12/2025
The independently owned telehealth platform offers same-day visits, prescription refills, and everyday care with transparent pricing and no insurance required Dover, Delaware, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Simple [...]
Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers
16/12/2025
ROSWELL, Ga., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cellution Biologics, Inc., a leader in regenerative allograft solutions, proudly announces the publication of its first peer-reviewed clinical article, “Bridging the Wound [...]
Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market
16/12/2025
New cash portion of offering includes >20% participation from Directors, Officers and Executive Management TAMPA, Fla. and LONDON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “ [...]

Pages